L-Glutamine Powder Specifications, COA and Bulk Sourcing

L-glutamine powder sample beside a batch COA for supplement manufacturing review
Table of Contents

L-glutamine powder is a fermentation-derived amino acid used in sports nutrition powders, protein blends, stick packs, capsules, tablets and other functional nutrition products. Bulk buyers should evaluate more than assay. Identity, particle size, moisture, density, contaminants, documentation and dosage-form performance can all affect material approval and commercial production.

Essencefield supplies L-glutamine powder within its broader nutrition ingredient portfolio. The final grade, specification, packaging, minimum order quantity and lead time are confirmed according to the approved source and individual project.

Commercial and Technical Supply Snapshot

ItemSupply reference
Product nameL-Glutamine Powder
CAS number56-85-9
Molecular formulaC5H10N2O3
Ingredient categoryFree-form amino acid
Typical sourceFermentation-derived
Typical assay≥99.0% on a dry basis when specified
AppearanceWhite to off-white crystalline powder
Available gradeFood, supplement or project-specific grade
Particle sizeProject-specific PSD
Bulk densityLot-dependent; available for filling assessment
CarrierNormally supplied without a carrier
Standard packingTypically 20–25 kg carton or fiber drum
Shelf lifeTypically 24 months unopened under recommended storage
Sample availabilityAvailable after project review
MOQProject-specific
Lead timeConfirmed with quotation
DocumentsCOA, specification or TDS, SDS and applicable declarations

These values are commercial references, not universal release limits. Buyers should request the current specification and a representative batch Certificate of Analysis before approving the source.

Request the current specification and representative COA before sampling or purchasing.

Identity, Source and Grade

L-glutamine is the optically active L-form of glutamine. The PubChem record for L-glutamine, maintained by the U.S. National Library of Medicine, identifies CAS 56-85-9 and the molecular formula C5H10N2O3.

The FDA’s Substances Added to Food database also lists L-glutamine and identifies technical effects that include nutrient supplementation and selected flavor-related uses. These references help establish chemical identity and food-use context but do not replace destination-market or finished-product review.

Commercial L-glutamine is commonly made through microbial fermentation followed by purification and crystallization. Where relevant, buyers should request confirmation of:

  • Manufacturing source and location
  • Fermentation origin
  • Non-animal status
  • GMO documentation
  • Allergen status
  • Country of origin
  • Batch traceability
  • Change-notification procedures

Fermentation origin does not replace batch testing. The commercial material must still comply with the approved identity, purity, physical-property and contaminant limits.

Interpreting grade terminology

Grade termBuyer interpretation
Food or supplement gradeIntended-use description; approve the actual specification and market requirements
USP or FCCConfirm the applicable monograph, edition, methods and batch compliance
Project-specific gradeLimits are agreed according to the formula and manufacturing process
Pharmaceutical gradeDo not rely on the phrase without a named pharmacopoeia, manufacturing scope and intended drug use

The correct material is the source that consistently meets the approved specification and works in the intended dosage form—not necessarily the one with the highest headline purity.

How to Review an L-Glutamine COA

A Certificate of Analysis should connect a specific production lot to the signed purchasing specification. It should identify the material, batch, analytical methods, acceptance criteria and actual results.

COA parameterBuyer reviewManufacturing relevanceWarning sign
IdentificationMethod, reference standard and resultConfirms the correct ingredientIdentity based only on appearance
AssayMethod, range and dry/as-is basisFormula and label calculationsReporting basis is not stated
Optical rotationSolvent, concentration and temperatureSupports L-form verificationResult lacks test conditions
Related substancesMethod and impurity profileHeat- or stability-sensitive productsNo impurity strategy
Loss on dryingMethod and numerical limitFlow, caking and storageResult approaches the upper limit
Particle sizeSieve limits or full PSDWetting, filling and segregationOnly “fine powder” is stated
Bulk densityMethod and representative rangeCapsule capacity and pack volumeSample and batch differ significantly
Heavy metalsIndividual element resultsExposure and market complianceOnly a general “pass” result
MicrobiologyNumerical limits and pathogen panelHygienic raw-material releaseOrganisms or methods are incomplete
Document consistencyProduct, lot and specification matchTraceability and batch releaseLabel and COA identify different lots

Essencefield’s product and quality framework may include HPLC or equivalent identification, assay, particle-size testing, bulk-density review, loss on drying, microbiology, elemental impurities and related-substance testing under an agreed specification.

For assay, buyers should confirm whether the result is reported on a dry or as-is basis. These calculations are not interchangeable when the material contains measurable moisture.

Identity methods should match the signed specification. HPLC retention comparison, FTIR and optical rotation can serve different purposes and should not be treated as interchangeable tests.

Microbiological and elemental impurity limits should reflect:

  • Destination-market requirements
  • Intended daily intake
  • Other ingredients in the formula
  • Dosage form
  • Target consumer
  • Finished-product limits

Element-specific results for lead, arsenic, cadmium and mercury are generally more useful than a combined heavy-metals result.

Particle Size, Bulk Density and Moisture

Chemical assay alone cannot predict how a powder will behave during blending, conveying, filling or consumer preparation.

Particle-size distribution

Particle size can affect:

  • Powder flow
  • Dust generation
  • Wetting and dispersion
  • Blend segregation
  • Mouthfeel
  • Sachet and capsule filling
  • Tablet compression

A finer material may wet more quickly but can retain air, produce more dust and flow less consistently. A controlled or slightly coarser grade may improve filling but require more mixing time.

The purchasing specification should therefore define a measurable mesh range or particle-size distribution based on application testing.

Bulk density

Bulk density affects:

  • Capsule fill capacity
  • Number of capsules per serving
  • Jar or pouch volume
  • Hopper behavior
  • Blend uniformity

Two sources with comparable assay results may require different capsule sizes or package volumes because their densities differ.

Capsule, sachet and tablet projects should use representative commercial material for density and flow testing. Laboratory samples may not reproduce the physical behavior of a production lot.

Moisture control

Loss on drying measures moisture removed under defined test conditions. Water activity indicates how much water is available within the powder system. These measurements are related but not equivalent.

Excess moisture can increase:

  • Caking
  • Poor hopper discharge
  • Fill-weight variation
  • Storage instability
  • Packaging requirements

Buyers should review moisture results together with the liner, outer package, storage conditions and transport humidity. Cool, dry storage and prompt resealing after opening help protect the material.

Dosage-Form Suitability

Dosage formMain advantageMain riskRecommended evaluation
Standalone powderAccommodates gram-level servingsCaking, taste and scoop variationFull-serving dispersion and packaging trial
Stick pack or sachetUnit-dose convenienceFill variation and humidityPilot filling and seal-integrity testing
Amino acid blendSupports multi-ingredient formulasDensity-driven segregationMulti-point blend-uniformity study
CapsuleFamiliar dosage formatExcessive capsule countDensity, flow and fill-weight assessment
TabletCompact presentationCompression or sticking problemsPilot compression and disintegration
Protein blendRelevant to sports nutritionClumping and flavor interactionComplete-formula mixing trial
GummyConsumer-friendly formatHeat and water exposureAssay and stability study
Ready-to-drinkImmediate convenienceSolution degradationFull process and shelf-life validation

High-dose powder products

Powder formats are generally the most practical option when a formula contains several grams of L-glutamine per serving.

Bench testing should use the intended serving size and complete formulation. Solubility in plain water does not predict wetting, taste or sediment in a product containing proteins, acids, minerals, sweeteners or flavors.

Essencefield’s powder supplement manufacturing support includes formula review, sample preparation, powder-behavior assessment, filling compatibility and packaging coordination.

Capsules and tablets

Capsule feasibility depends on bulk density, flowability, shell size and active loading. A low-density material may require more capsules than the brand considers commercially acceptable.

Tablet projects also require testing for:

  • Compressibility
  • Hardness
  • Friability
  • Capping
  • Sticking
  • Disintegration

A compliant raw-material COA does not demonstrate that the ingredient will run successfully on commercial filling or compression equipment.

Gummies and liquid products

Heat and water increase stability risk. A ready-to-mix powder may therefore be more practical than a long-shelf-life liquid.

Published research on the stability of L-glutamine in solution found that degradation varies with solution and storage conditions and can produce ammonia. Gummies, liquid products and heat-exposed formulas should be supported by finished-product stability studies.

Evidence and Claim Boundaries

Positioning areaEvidence interpretationCommercial limitation
Intestinal barrierMechanistic and selected clinical evidence existsDo not imply treatment of gastrointestinal disease
Sports nutritionGlutamine participates in amino acid and nitrogen metabolismDo not promise muscle growth or improved performance without substantiation
Immune functionGlutamine is involved in immune-cell metabolismAvoid infection-prevention and disease claims
Prescription useApproved L-glutamine drugs have defined indicationsDrug approval does not transfer to supplement ingredients

A 2024 systematic review and meta-analysis reported an overall effect on intestinal permeability across the included trials, but the results depended on population, dose and study design.

Evidence from defined clinical groups should not be converted into universal supplement claims. FDA guidance on structure/function claims distinguishes statements about normal physiological roles from claims that a product diagnoses, treats, cures or prevents disease.

Prescription L-glutamine products operate under a separate drug framework. The DailyMed listing for Endari does not establish treatment claims for conventional food- or supplement-grade raw material.

Supplier Qualification and Batch Approval

A controlled approval process should connect the manufacturer, specification, documents, sample and commercial batch.

1. Confirm the manufacturer and source

Identify:

  • Legal manufacturer
  • Distributor or exporter
  • Production location
  • Country of origin
  • Responsible quality organization
  • Change-notification process

The supply chain should support traceability, deviation review, complaint handling and recall investigation.

2. Approve the specification

Define the required:

  • Identity methods
  • Assay and reporting basis
  • Particle-size distribution
  • Moisture limit
  • Bulk density where relevant
  • Microbiological limits
  • Elemental impurity limits
  • Packaging
  • Storage
  • Shelf life or retest period

3. Cross-check batch documents

Confirm that the following information matches across the specification, COA, label and declarations:

  • Product name
  • CAS number
  • Product code
  • Batch number
  • Manufacturing source
  • Specification version
  • Test methods
  • Manufacture and retest dates
  • Certification holder and scope

Essencefield’s raw-material quality process connects supplier qualification, specification approval, COA review, incoming inspection, release decisions and batch traceability.

4. Test a representative sample

The sample should represent the proposed commercial source and grade.

Evaluation may include:

  • Identity verification
  • Dispersion testing
  • Sensory review
  • Blend-uniformity studies
  • Capsule or tablet trials
  • Pilot production
  • Preliminary stability observations

Essencefield’s ingredient sourcing service supports specification matching, document review, sample coordination, testing and bulk supply planning.

5. Review multiple batches

Where data are available, compare several recent COAs for:

  • Assay
  • Moisture
  • Particle size
  • Density
  • Microbiology
  • Elemental impurities

A multi-batch review provides a better indication of source consistency than a single ideal COA.

6. Establish change control

Require notification for significant changes involving:

  • Manufacturing site
  • Production route
  • Raw-material source
  • Specification
  • Analytical method
  • Particle-size process
  • Packaging
  • Shelf life
  • Regulatory status

A batch should be placed on hold when its identity is unclear, its methods differ from the approved specification or its documents cannot be linked to the approved source.

Documentation, Price and RFQ

Standard document package

DocumentProcurement purpose
Batch COAConfirms actual results against the specification
Specification or TDSDefines identity, limits and technical properties
SDSSupports handling, storage and transport review
Allergen statementSupports formula and label assessment
GMO statementSupports sourcing requirements
Vegan or non-animal statementConfirms origin suitability where required
Irradiation statementSupports market and customer review
Country-of-origin statementSupports imports and traceability
Third-party reportProvides independent confirmation when requested

Essencefield’s testing and certification support can coordinate technical documents and third-party testing where required. Certificate applicability should be confirmed against the product, manufacturing facility and destination market.

Factors affecting bulk price

Bulk quotations can vary according to:

  • Grade and assay
  • Analytical scope
  • Particle-size requirements
  • Contaminant limits
  • Documents and declarations
  • Packaging
  • Order volume
  • Shipping route
  • Incoterm
  • Lead time

Compare quotations using the same specification, test scope, packaging and delivery term.

Information required for an RFQ

Provide:

  1. Product name and required grade
  2. Intended dosage form
  3. Target serving or inclusion level
  4. Required assay and identity methods
  5. Particle-size preference
  6. Moisture and contaminant limits
  7. Trial quantity
  8. Estimated annual demand
  9. Destination country
  10. Required documents
  11. Packaging preference
  12. Target delivery date
  13. Third-party testing requirements

A complete RFQ allows the offered material, documentation and price to be matched to the actual manufacturing project.

Essencefield L-Glutamine Supply Support

Essencefield supports specification and source matching, sample and COA review, dosage-form assessment, testing coordination and bulk supply planning.

Project-specific particle size, packaging, MOQ, lead time and document requirements are confirmed after technical review. The approved source can then be connected to incoming inspection, commercial batch release and repeat-order traceability.

Contact Essencefield to request the current L-glutamine specification, representative COA, sample, packaging details and quotation.

Request a Manufacturing Quote

Please use the form below to share your ingredient requirements—product category, target application, desired specifications (e.g., assay/ratio, mesh size, carrier), and estimated order quantity. If you need OEM/private label, include dosage form and key label claims. We’ll route your request to the right team and recommend suitable ingredients, testing/documentation options, packaging, and lead times. You’ll receive indicative pricing, MOQ, and a sample/approval plan.

Picture of Essencefield Editorial Team | Ingredient Science, Quality & OEM Manufacturing

Essencefield Editorial Team | Ingredient Science, Quality & OEM Manufacturing

We publish technical guides for B2B sourcing and formulation of botanical ingredients, including typical COA/Spec ranges, risk-based testing plans, documentation, and OEM/private-label manufacturing. Content is reviewed to align with manufacturing feasibility, batch traceability, and quality control practices used for global export projects.

Reviewed By: Essencefield QA & Technical Team (Quality System)

Documents (on request): COA · TDS/Spec · SDS · Allergen/GMO statements · Regulatory declarations (market-dependent)

More Posts